Healthcare Industry News:  Baxter International 

Devices Personnel

 News Release - March 11, 2008

Haemonetics(R) Appoints Peter Allen as Chief Marketing Officer

BRAINTREE, Mass., March 11 (HSMN NewsFeed) -- Haemonetics Corporation announced today the appointment of Peter Allen to the newly created position of Chief Marketing Officer. In this position, Mr. Allen will assume responsibility for global marketing of Haemonetics' full product portfolio in addition to his current responsibilities as President, Donor Division.

Brian Concannon, Chief Operating Officer, commented, "Pete Allen was an architect of our strategic vision to be the global leader in blood management solutions for our customers. He has established strong relationships with our customers and gained keen insight into customer needs and market trends. We are pleased that he will be leading Haemonetics' marketing strategy as we leverage the Haemonetics brand in our expanding markets."

Through its blood management solutions offerings, Haemonetics markets to hospitals, blood banks, and plasma collection customers. Haemonetics' marketing efforts support improving patient care as it relates to blood transfusions while simultaneously reducing total healthcare costs.

Mr. Concannon added, "Haemonetics is uniquely qualified to offer a full suite of business solutions related to blood management. We are the only company that operates across the blood supply chain from the blood donor to the patient transfusion. As importantly, we are the only company that offers the depth of products, through our devices, services, and software solutions, required to truly meet our customers' blood management needs. Under Pete Allen's leadership, we will drive a cohesive, global message of blood management solutions for our customers."

Mr. Allen, age 49, joined Haemonetics in 2003 as President, Donor Division. He has over twenty five years experience in health care and medical products. Prior to joining Haemonetics, Mr. Allen was Vice President of The Aethena Group, a private equity firm providing services to the global healthcare industry. From 1998 to 2001, he held various positions including Vice President of Sales and the Oncology Business at Syncor International, a provider of radiopharmaceutical and comprehensive medical imaging services. Previously, he held executive level positions in sales, marketing and operations in DataMedic, Inc., Enterprise Systems, Inc./HBOC, and Robertson Lowstuter, Inc. Mr. Allen has also worked in sales at American Hospital Supply Corporation and Baxter International, Inc. Mr. Allen is a finance graduate of Lehigh University.

Haemonetics (NYSE: HAE ) is a global healthcare company dedicated to providing innovative blood management solutions for our customers. Together, our devices and consumables, IT products, and consulting services deliver a suite of business solutions to help our customers improve clinical outcomes and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.


Source: Haemonetics

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.



FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.